The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells

scientific article published in December 2002

The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/VIRO.2002.1556
P698PubMed publication ID12504560
P5875ResearchGate publication ID10970417

P50authorCharles GroseQ57329554
Ann ArvinQ4766238
P2093author name stringJay Lee
Marvin Sommer
Chengjun Mo
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)176-186
P577publication date2002-12-01
P1433published inVirologyQ7934867
P1476titleThe requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells
P478volume304

Reverse relations

cites work (P2860)
Q40234780A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
Q35956960Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Q45359726Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
Q36099097Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication
Q34004072Cholesterol dependence of varicella-zoster virion entry into target cells
Q34434777Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus
Q36491044Conserved herpesvirus protein kinases
Q37033241Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry
Q43161154Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts
Q37596465Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells
Q90714289Duck plague virus gE serves essential functions during the virion final envelopment through influence capsids budding into the cytoplasmic vesicles
Q35101360Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection
Q37596576Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo
Q33591823Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection
Q40041720Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
Q37252780Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaques
Q39753125Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells
Q39320331Initial Contact: The First Steps in Herpesvirus Entry.
Q24307918Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread
Q37932527Molecular studies of the Oka varicella vaccine
Q35076854Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells
Q34977329Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo
Q33640129Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses
Q33724286Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo
Q45370931Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5
Q35947774The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor
Q33987514The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors
Q27330259The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface
Q35543796The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Q33554456The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection
Q60938762Varicella Virus-Host Interactions During Latency and Reactivation: Lessons From Simian Varicella Virus
Q39998958Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.
Q39214502Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis
Q33833934Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model
Q36424473Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread
Q36987139Varicella-zoster virus infection of human neural cells in vivo.

Search more.